Paxman AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PAX.ST research report →
Companypaxmanscalpcooling.com
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment in Europe, the United States, Mexico, Japan, Oceania, rest of Asia, and South and Central America. It serves various cancer centers and hospitals. The comapny has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device.
- CEO
- Richard Paxman
- IPO
- 2017
- Employees
- 105
- HQ
- Karlshamn, SE
Price Chart
Valuation
- Market Cap
- $1.16B
- P/E
- -72.20
- P/S
- 3.71
- P/B
- 2.87
- EV/EBITDA
- 36.53
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 47.75%
- Op Margin
- 1.50%
- Net Margin
- -5.14%
- ROE
- -4.20%
- ROIC
- 1.09%
Growth & Income
- Revenue
- $313.35M · 23.85%
- Net Income
- $-16,715,000 · -141.58%
- EPS
- $-0.76 · -136.02%
- Op Income
- $4.26M
- FCF YoY
- -153.15%
Performance & Tape
- 52W High
- $85.80
- 52W Low
- $41.00
- 50D MA
- $47.86
- 200D MA
- $57.36
- Beta
- 0.45
- Avg Volume
- 19.15K
Get TickerSpark's AI analysis on PAX.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PAX.ST Coverage
We haven't published any research on PAX.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PAX.ST Report →